Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | CTSA | P10619 | 1/20 | 0.34 |
| ▸ | APLNR | P35414 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20738686 | 0.80 | NOS1 (0.41) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL11458946 | 0.80 | NOS1 (0.41) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL3248176 | 0.80 | NOS1 (0.46) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL6010207 | 0.80 | NOS1 (0.41) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL30209038 | 0.80 | NOS1 (0.46) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL23869812 | 0.80 | NOS1 (0.41) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL12179230 | 0.80 | NOS1 (0.41) | NOS1CTSAAPLNRALDH1A1GAA | |
| SCHEMBL14226108 | 0.77 | TLR8 (0.33) | TLR8TLR7 | |
| SCHEMBL29271546 | 0.77 | NOS1 (0.43) | NOS1CTSAAPLNR | |
| SCHEMBL12848866 | 0.77 | NOS1 (0.38) | NOS1CTSAAPLNRTLR8TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116814525-B | Culture medium for culturing Babylonia embryos and method for culturing Babylonia embryos outside capsules | 广东海洋大学 | 2024-04-30 | — | — | CN | claimed |
| CN-117223657-B | Method for cultivating low-salt-resistant long-speed and fast Babylonia | 广东海洋大学 | 2024-04-05 | — | — | CN | claimed |
| CN-114903128-B | Crayfish compound feed and preparation method thereof | 湖南文和友乔口小龙虾养殖有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117223657-A | Method for cultivating low-salt-resistant long-speed and fast Babylonia | 广东海洋大学 | 2023-12-15 | — | — | CN | claimed |
| CN-116814525-A | Culture medium for culturing Babylonia embryos and method for culturing Babylonia embryos outside capsules | 广东海洋大学 | 2023-09-29 | — | — | CN | claimed |
| CN-116218427-A | Acrylic ester adhesive and preparation method and application thereof | 华东理工大学 | 2023-06-06 | — | — | CN | claimed |
| US-20240199604-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-20 | — | — | US | disclosed |
| CN-116814525-B | Culture medium for culturing Babylonia embryos and method for culturing Babylonia embryos outside capsules | 广东海洋大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-116814525-B | Culture medium for culturing Babylonia embryos and method for culturing Babylonia embryos outside capsules | 广东海洋大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-117223657-B | Method for cultivating low-salt-resistant long-speed and fast Babylonia | 广东海洋大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-117084204-B | Buffer solution for improving hatching rate and survival rate of eastern conch oocysts and method for hatching eastern conch oocysts | 广东海洋大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-114903128-B | Crayfish compound feed and preparation method thereof | 湖南文和友乔口小龙虾养殖有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117223657-A | Method for cultivating low-salt-resistant long-speed and fast Babylonia | 广东海洋大学 | 2023-12-15 | — | — | CN | disclosed |
| US-20080015195-A1 | Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase | METABASIS THERAPEUTICS, INC. (US) | 2008-01-17 | — | — | US | disclosed |
| US-7312219-B2 | Heteroaromatic inhibitors of fructose 1,6-bisphosphatase | METABASIS THERAPEUTICS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070244096-A1 | Fused Bicyclic Nitrogen-Containing Heterocycles | JAPAN TOBACCO INC. (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070232571-A1 | Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase | METABASIS THERAPEUTICS, INC. (US) | 2007-10-04 | — | — | US | disclosed |
| US-7244727-B2 | Fused bicyclic nitrogen-containing heterocycles | JAPAN TOBACCO INC. (JP) | 2007-07-17 | — | — | US | disclosed |
| US-20070135467-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-06-14 | — | — | US | disclosed |
| US-6579553-B1 | Reaction product cysteine, hydrogen sulfide, ammonium sulfide and extracellular liquid fusarium extracts used as food flavors | ZENECA LIMITED (GB) | 2003-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199604-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | MAPT, HTT, PSEN1 | NOS1 4315/4885CTSA 1917/4885APLNR 528/4885 |
| US-20080015195-A1 | Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase | FBP1, ALDOA, G6PC1 | NOS1 3032/4885CTSA 2347/4885APLNR 4322/4885 |
| US-20070135467-A1 | HETEROCYCLIC CETP INHIBITORS | CETP, CES1, NPC1 | NOS1 3695/4885CTSA 348/4885APLNR 4348/4885 |
| US-20070244096-A1 | Fused Bicyclic Nitrogen-Containing Heterocycles | PC, HCCS, MYC | NOS1 833/4885CTSA 1117/4885APLNR 1068/4885 |
| US-20070232571-A1 | Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase | FBP1, ALDOA, G6PC1 | NOS1 3032/4885CTSA 2347/4885APLNR 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.